Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS

scientific article (publication date: June 2003)

Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/NSB935
P698PubMed publication ID12754496
P5875ResearchGate publication ID10752621

P50authorSvetlana AntonyukQ51971191
Jennifer Stine ElamQ75569251
Todd O. YeatesQ32063648
P2093author name stringAlexander B Taylor
P John Hart
S Samar Hasnain
Joan Selverstone Valentine
Lawrence J Hayward
Jorge A Rodriguez
Richard Strange
Peter A Doucette
P2860cites workAggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1Q22299419
Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregationQ24530946
Improved methods for building protein models in electron density maps and the location of errors in these modelsQ26776980
Crystallography & NMR System: A New Software Suite for Macromolecular Structure DeterminationQ26778405
PROCHECK: a program to check the stereochemical quality of protein structuresQ26778411
Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvementQ49023143
Natural history of amyotrophic lateral sclerosis in a database population Validation of a scoring system and a model for survival predictionQ52340479
An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondriaQ54965159
Improved Fourier coefficients for maps using phases from partial structures with errorsQ56877556
Sequence Communication: Tabulation of transthyretin (TTR) variants as of 1/1/2000Q58011100
Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosisQ72621641
Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutaseQ73316561
The metal binding properties of the zinc site of yeast copper-zinc superoxide dismutase: implications for amyotrophic lateral sclerosisQ73810547
Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitriteQ73829106
Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loadingQ77754821
[33] AMoRe: An automated molecular replacement program packageQ88661432
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structuresQ26778412
The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosisQ27641126
Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutaseQ27731976
Use of TLS parameters to model anisotropic displacements in macromolecular refinementQ27860499
Rapid automated molecular replacement by evolutionary searchQ27860711
Errors in protein structuresQ27860776
Further additions to MolScript version 1.4, including reading and contouring of electron-density mapsQ27860974
Efficient anisotropic refinement of macromolecular structures using FFTQ27861028
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisQ28131805
Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injuryQ28511628
Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutationQ29547561
MOLREP: an Automated Program for Molecular ReplacementQ29642797
Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the proteinQ30425734
Amyloid fibers are water-filled nanotubesQ31048768
Amyotrophic lateral sclerosis: a proposed mechanismQ34066549
Toxic proteins in neurodegenerative diseaseQ34133493
Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseasesQ34142252
Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosisQ34718757
Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.Q35818148
A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxideQ37550536
Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.Q38291855
Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegenerationQ40610035
Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosisQ40975834
Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosisQ41237348
Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neuronsQ41644415
Loss of in vitro metal ion binding specificity in mutant copper-zinc superoxide dismutases associated with familial amyotrophic lateral sclerosisQ41712822
Copper(2+) binding to the surface residue cysteine 111 of His46Arg human copper-zinc superoxide dismutase, a familial amyotrophic lateral sclerosis mutantQ41746192
Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosisQ42846381
Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissuesQ43821139
High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulationQ43918294
Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding siteQ44070818
ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.Q46135324
Arrangement of subunits and ordering of beta-strands in an amyloid sheetQ46564095
Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper/zinc superoxide dismutaseQ46566731
Axonal transport of mutant superoxide dismutase 1 and focal axonal abnormalities in the proximal axons of transgenic mice.Q47692402
Neurodegenerative disease: amyloid pores from pathogenic mutationsQ48544171
P433issue6
P921main subjectamyotrophic lateral sclerosisQ206901
P304page(s)461-7
P577publication date2003-06-01
P1433published inNature structural biologyQ26842658
P1476titleAmyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS
P478volume10

Reverse relations

cites work (P2860)
Q37549326"Native-like aggregation" of the acylphosphatase from Sulfolobus solfataricus and its biological implications
Q405771063' untranslated region in a light neurofilament (NF-L) mRNA triggers aggregation of NF-L and mutant superoxide dismutase 1 proteins in neuronal cells.
Q30668587A common 'aggregation-prone' interface possibly participates in the self-assembly of human zona pellucida proteins.
Q37431412A common property of amyotrophic lateral sclerosis-associated variants: destabilization of the copper/zinc superoxide dismutase electrostatic loop
Q38291545A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis.
Q41659008A mechanism for propagated SOD1 misfolding from frustration analysis of a G85R mutant protein assembly.
Q51261579A misfolded dimer of Cu/Zn-superoxide dismutase leading to pathological oligomerization in amyotrophic lateral sclerosis.
Q92863745A model for gain of function in superoxide dismutase
Q36995776A novel variant of human superoxide dismutase 1 harboring amyotrophic lateral sclerosis-associated and experimental mutations in metal-binding residues and free cysteines lacks toxicity in vivo
Q33638268A prion-like mechanism for the propagated misfolding of SOD1 from in silico modeling of solvated near-native conformers
Q37170196A quantitative examination of the role of cargo-exerted forces in axonal transport
Q40409233Aberrantly increased hydrophobicity shared by mutants of Cu,Zn-superoxide dismutase in familial amyotrophic lateral sclerosis.
Q34383094Aggregation modulating elements in mutant human superoxide dismutase 1.
Q34905853Amyloid formation by globular proteins under native conditions
Q52856652Amyloid formation under physiological conditions proceeds via a native-like folding intermediate.
Q33495551Amyloidogenic regions and interaction surfaces overlap in globular proteins related to conformational diseases
Q36986109An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril
Q38174873An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis
Q51591442An in silico study of the effect of SOD1 electrostatic loop dynamics on amyloid‑like filament formation.
Q35224579Analysis of mutant SOD1 electrophoretic mobility by Blue Native gel electrophoresis; evidence for soluble multimeric assemblies
Q49907306Atomic structures of corkscrew-forming segments of SOD1 reveal varied oligomer conformations
Q33891008Beta arcades: recurring motifs in naturally occurring and disease-related amyloid fibrils
Q44931860Bicarbonate and active site zinc modulate the self-peroxidation of bovine copper-zinc superoxide dismutase
Q28393352Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status
Q38069389Breaking the amyloidogenicity code: methods to predict amyloids from amino acid sequence
Q36407372Cargo distributions differentiate pathological axonal transport impairments
Q38766626Cellular Redox Systems Impact the Aggregation of Cu,Zn Superoxide Dismutase Linked to Familial Amyotrophic Lateral Sclerosis
Q28277615Cellular copper distribution: a mechanistic systems biology approach
Q57261217Chapter 14 Familial amyotrophic lateral sclerosis
Q27658869Characterization of a Covalent Polysulfane Bridge in Copper−Zinc Superoxide Dismutase,
Q35709805Characterization of heparin-induced glyceraldehyde-3-phosphate dehydrogenase early amyloid-like oligomers and their implication in α-synuclein aggregation.
Q51017813Characterizing Structural Stability of Amyloid Motif Fibrils Mediated by Water Molecules
Q41807230Characterizing intermolecular interactions that initiate native-like protein aggregation
Q26996075Chemical approaches to detect and analyze protein sulfenic acids
Q24299487Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis
Q34480306Common dynamical signatures of familial amyotrophic lateral sclerosis-associated structurally diverse Cu, Zn superoxide dismutase mutants
Q35928006Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis.
Q39972533Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis
Q42694170Computational methods for identifying a layered allosteric regulatory mechanism for ALS‐causing mutations of Cu‐Zn superoxide dismutase 1
Q38551857Conformational Disorder of the Most Immature Cu, Zn-Superoxide Dismutase Leading to Amyotrophic Lateral Sclerosis.
Q34310311Copper-based pulsed dipolar ESR spectroscopy as a probe of protein conformation linked to disease states
Q38769938Copper-zinc superoxide dismutase is activated through a sulfenic acid intermediate at a copper ion entry site
Q35234117Crystallizing ideas about Parkinson's disease
Q33680425DNA-Triggered Aggregation of Copper, Zinc Superoxide Dismutase in the Presence of Ascorbate
Q44971569Decrease of Hsp25 protein expression precedes degeneration of motoneurons in ALS-SOD1 mice
Q34572921Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS.
Q57944931Dehydration stability of amyloid fibrils studied by AFM
Q33897544Destabilization of apoprotein is insufficient to explain Cu,Zn-superoxide dismutase-linked ALS pathogenesis.
Q36512177Detergent-insoluble aggregates associated with amyotrophic lateral sclerosis in transgenic mice contain primarily full-length, unmodified superoxide dismutase-1.
Q40496567Different immunoreactivity against monoclonal antibodies between wild-type and mutant copper/zinc superoxide dismutase linked to amyotrophic lateral sclerosis
Q37646220Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants.
Q50204472Direct Conversion of an Enzyme from Native-like to Amyloid-like Aggregates within Inclusion Bodies
Q37375549Disease-associated mutations at copper ligand histidine residues of superoxide dismutase 1 diminish the binding of copper and compromise dimer stability
Q27662078Disrupted Zinc-Binding Sites in Structures of Pathogenic SOD1 Variants D124V and H80R
Q45107835Dissociation of human copper-zinc superoxide dismutase dimers using chaotrope and reductant. Insights into the molecular basis for dimer stability
Q24544265Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice
Q34788369Disulfide-reduced ALS variants of Cu, Zn superoxide dismutase exhibit increased populations of unfolded species
Q40885460Dynamic properties of SOD1 mutants can predict survival time of patients carrying familial amyotrophic lateral sclerosis.
Q27690644Edge strand engineering prevents native-like aggregation in Sulfolobus solfataricus acylphosphatase
Q36507250Evaluation of a symmetry-based strategy for assembling protein complexes
Q91809748Evolutionary Analyses of Sequence and Structure Space Unravel the Structural Facets of SOD1
Q64241123Experimental Mutations in Superoxide Dismutase 1 Provide Insight into Potential Mechanisms Involved in Aberrant Aggregation in Familial Amyotrophic Lateral Sclerosis
Q34082710Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants
Q35012498Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials.
Q36398045Fibrillation precursor of superoxide dismutase 1 revealed by gradual tuning of the protein-folding equilibrium
Q37619322Folding of human superoxide dismutase: disulfide reduction prevents dimerization and produces marginally stable monomers
Q57944846From Molecular to Supramolecular Amyloid Structures: Contributions from Fiber Diffraction and Electron Microscopy
Q46654946Fully metallated S134N Cu,Zn-superoxide dismutase displays abnormal mobility and intermolecular contacts in solution
Q27655747Functional features cause misfolding of the ALS-provoking enzyme SOD1
Q37079411Hacking the code of amyloid formation: the amyloid stretch hypothesis
Q40389314HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS.
Q46807674Human SOD1 before harboring the catalytic metal: solution structure of copper-depleted, disulfide-reduced form
Q34564980Human pancreatitis-associated protein forms fibrillar aggregates with a native-like conformation
Q64982638Hydrogen-Deuterium Exchange Profiles of Polyubiquitin Fibrils.
Q34317439Identification of a misfolded region in superoxide dismutase 1 that is exposed in amyotrophic lateral sclerosis.
Q33772493Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.
Q33541145Improving binding specificity of pharmacological chaperones that target mutant superoxide dismutase-1 linked to familial amyotrophic lateral sclerosis using computational methods
Q64231004Infinite Assembly of Folded Proteins in Evolution, Disease, and Engineering
Q38518708Informatics-assisted protein profiling in a transgenic mouse model of amyotrophic lateral sclerosis.
Q57204416Inhibition of Chaperone Activity Is a Shared Property of Several Cu,Zn-Superoxide Dismutase Mutants That Cause Amyotrophic Lateral Sclerosis
Q33942778Insights into SOD1-linked amyotrophic lateral sclerosis from NMR studies of Ni(2+)- and other metal-ion-substituted wild-type copper-zinc superoxide dismutases
Q30155471Intermolecular transmission of superoxide dismutase 1 misfolding in living cells
Q30159818Local unfolding in a destabilized, pathogenic variant of superoxide dismutase 1 observed with H/D exchange and mass spectrometry
Q35873804Local unfolding of Cu, Zn superoxide dismutase monomer determines the morphology of fibrillar aggregates
Q58608539Loss of charge mutations in solvent exposed Lys residues of superoxide dismutase 1 do not induce inclusion formation in cultured cell models
Q46851121Many roads lead to Rome? Multiple modes of Cu,Zn superoxide dismutase destabilization, misfolding and aggregation in amyotrophic lateral sclerosis
Q37707829Mapping superoxide dismutase 1 domains of non-native interaction: roles of intra- and intermolecular disulfide bonding in aggregation
Q37448164Metal deficiency increases aberrant hydrophobicity of mutant superoxide dismutases that cause amyotrophic lateral sclerosis
Q33559671Metal-free ALS variants of dimeric human Cu,Zn-superoxide dismutase have enhanced populations of monomeric species
Q64084482Microsecond sub-domain motions and the folding and misfolding of the mouse prion protein
Q47382895Molecular dynamics of a far positioned SOD1 mutant V14M reveals pathogenic misfolding behavior
Q27645269Molecular dynamics using atomic-resolution structure reveal structural fluctuations that may lead to polymerization of human Cu Zn superoxide dismutase
Q50069615Molecular mechanisms underlying the impact of mutations in SOD1 on its conformational properties associated with amyotrophic lateral sclerosis as revealed with molecular modelling
Q36062875Mutant SOD1 forms ion channel: implications for ALS pathophysiology
Q30159679Mutant SOD1 instability: implications for toxicity in amyotrophic lateral sclerosis
Q34438898Nonamyloid aggregates arising from mature copper/zinc superoxide dismutases resemble those observed in amyotrophic lateral sclerosis
Q89706496Nucleation and kinetics of SOD1 aggregation in human cells for ALS1
Q30101060Parsing Disease-relevant Protein Modifications from Epiphenomena: Perspective on the Structural Basis of SOD1-Mediated ALS.
Q46171494Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.
Q46375493Photoinduced fibrils formation of chicken egg white lysozyme under native conditions
Q35125315Posttranslational modifications in Cu,Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis.
Q38176187Prion-like activity of Cu/Zn superoxide dismutase: implications for amyotrophic lateral sclerosis.
Q37417809Probing the free energy landscapes of ALS disease mutants of SOD1 by NMR spectroscopy
Q46728737Proteasomal degradation of mutant superoxide dismutases linked to amyotrophic lateral sclerosis
Q33356197Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival
Q35592405Protein aggregation in motor neurone disorders.
Q47126292Real-Time Observation of the Interaction between Thioflavin T and an Amyloid Protein by Using High-Sensitivity Rheo-NMR.
Q36497696Redox properties of the disulfide bond of human Cu,Zn superoxide dismutase and the effects of human glutaredoxin 1
Q36673087SOD1 exhibits allosteric frustration to facilitate metal binding affinity
Q37479003SOD1-associated ALS: a promising system for elucidating the origin of protein-misfolding disease
Q42664185Small molecules present in the cerebrospinal fluid metabolome influence superoxide dismutase 1 aggregation
Q27648424Structural Characterization of Zinc-deficient Human Superoxide Dismutase and Implications for ALS
Q27679379Structural Consequences of Cysteinylation of Cu/Zn-Superoxide Dismutase
Q27653849Structural and Biophysical Properties of the Pathogenic SOD1 Variant H46R/H48Q †
Q27657645Structural and biophysical properties of metal-free pathogenic SOD1 mutants A4V and G93A
Q27654799Structural and dynamic aspects related to oligomerization of apo SOD1 and its mutants
Q36944974Structural basis of infectious and non-infectious amyloids
Q42252269Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg.
Q34947293Structural insights into functional and pathological amyloid
Q36693082Structural models of amyloid-like fibrils
Q27670773Structural switching of Cu,Zn-superoxide dismutases at loop VI: insights from the crystal structure of 2-mercaptoethanol-modified enzyme
Q36297476Structural, Functional, and Immunogenic Insights on Cu,Zn Superoxide Dismutase Pathogenic Virulence Factors from Neisseria meningitidis and Brucella abortus
Q27664114Structures of mouse SOD1 and human/mouse SOD1 chimeras
Q21136374Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis
Q35049047Superoxide dismutases and superoxide reductases
Q37771718Taking charge of proteins from neurodegeneration to industrial biotechnology
Q91419222The biophysics of superoxide dismutase-1 and amyotrophic lateral sclerosis
Q35928026The effect of amyotrophic lateral sclerosis-linked exogenous SOD1-G93A on electrophysiological properties and intracellular calcium in cultured rat astrocytes
Q33891158The effect of red pigment on the amyloidization of yeast proteins
Q37375579The effects of glutaredoxin and copper activation pathways on the disulfide and stability of Cu,Zn superoxide dismutase
Q28287224The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis
Q44697040The role of solvent exclusion in the interaction between D124 and the metal site in SOD1: implications for ALS.
Q34993111The structural biochemistry of the superoxide dismutases.
Q33356208The threat of instability: neurodegeneration predicted by protein destabilization and aggregation propensity
Q35623240Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis
Q92032360Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1
Q35763674Thermal fluctuations of immature SOD1 lead to separate folding and misfolding pathways
Q27687002Three-dimensional domain swapping and supramolecular protein assembly: insights from the X-ray structure of a dimeric swapped variant of human pancreatic RNase
Q27002139Top-down proteomics in health and disease: challenges and opportunities
Q37416520Transient structural distortion of metal-free Cu/Zn superoxide dismutase triggers aberrant oligomerization
Q93061331Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection
Q37877295Understanding the complex mechanisms of β2-microglobulin amyloid assembly
Q40440970Unsaturated fatty acids induce cytotoxic aggregate formation of amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutants.
Q92021353β-Methylamino-L-alanine substitution of serine in SOD1 suggests a direct role in ALS etiology

Search more.